The degradation of (RS)-MCPP was investigated in an anaerobic membrane bioreactor (AnMBR) using nitrate as an available electron acceptor under different COD/NO(3)(-)-N ratios. Results showed high soluble COD removal efficiency (80-93%) when the reactor was operated at high COD/NO(3)(-)-N ratios. However, the COD removal started to decline (average 15%) at high nitrate concentrations coinciding with a drop in nitrate removal efficiency to 37%, suggesting that the denitrification activity dropped and affected the AnMBR performance when nitrate was the predominant electron acceptor. Additionally, the removal efficiency of (RS)-MCPP increased from 2% to 47% with reducing COD/NO(3)(-)-N ratios, whilst the (RS)-MCPP specific utilisation rate (SUR) was inversely proportional to the COD/NO(3)(-)-N ratio, suggesting that a lower COD/NO(3)(-)-N ratios had a positive influence on the (RS)-MCPP SUR. Although nitrate had a major impact on methane production rates, the methane composition was stable (approximately 80%) for COD/NO(3)(-)-N ratios of 23 or more.
The effects of Mecoprop (RS)-MCPP were investigated in an anaerobic membrane bioreactor (AnMBr) fed with synthetic wastewater containing stepwise increases in Mecoprop concentration, 5-200 mg L(-1) over 240 days. Effects were observed in terms of soluble chemical oxygen demand (COD) removal efficiency, volatile fatty acid (VFA) production, and methane yield. Soluble COD removal efficiency was stable at Mecoprop concentrations below 200 (±3) mg L(-1), with an average of 98 (±0.7)% removal. However, at 200 (±3) mg L(-1) Mecoprop, the COD removal efficiency decreased gradually to 94 (±1.5)%. At 5 mg L(-1) Mecoprop, acetic and propionic acid concentrations increased by 60% and 160%, respectively. In contrast, when Mecoprop was increased to 200 (±3) mg L(-1), the formation and degradation of acetate was unaffected by the higher Mecoprop concentration, acetate remaining below 35 mg L(-1). Increases in the Mecoprop specific utilization rate were observed as Mecoprop was increased stepwise between 5 and 200 mg L(-1).